Sensius

another very insightful, inspiring and yet very practical session from Techleap PolePosition program!

The #rotterdam network of Rotterdam Square is an excellent place for @sensius to be part of, located within Erasmus MC and all the great people who work there!

proud to have had the opportunity from UCEA - Family Office Group to demonstrate how Thermotherapy by Sensius is to become the 4th pillar in cancer treatment.

Sensius and AMG Medtech, their UK sales agent, hosted a hybrid meeting during European Society for Radiotherapy and Oncology (ESTRO) 2024 in Glasgow over the weekend. Clinicians from continental Europe and the UK attended the meeting to consider options for integrating the different trial protocols that have been developed during previous meetings. The aim is to coordinate and integrate the clinical trials protocols throughout Europe, the UK and the USA. One of the meeting's outcomes was the establishment of a global Trial Leadership Team comprising the PI's representing the various regional trials.

🥳 We're thrilled to introduce the latest cohort of groundbreaking ventures selected for the Pole Position programme - Meet Batch #6 Life Sciences & Health! 🎉 🧬These ambitious ventures are set to revolutionise the field, addressing critical health challenges globally. From tackling chronic knee pain to offering hormone-free contraception and advancing cancer treatment, each company is bringing cutting-edge solutions to benefit the future of the Netherlands and beyond 🚀 👏 A warm welcome to: ATRO Medical BV Choice - Every Child Desired Digi.Bio IMcoMET Loop Robots Sensible Healthcare Systems Sensius Spatium Medical STIL 🔍 Discover how these ventures are reshaping the future of Healthcare & Life Sciences with their groundbreaking solutions! 👉 https://hubs.li/Q02t7wJj0 A special thanks to our selection committee: Sjaak Vink, Meike Bomhof, Peter Haasjes and Soukaina Adnane-Murphy 🧡 #Techleap #Startups #HealthcareRevolution #PolePosition #LifeSciences #HealthTech #Innovation

US Clinical trial meeting Phoenix              During the American Society for Radiation Oncology Head and Neck conference in Phoenix AZ, Sensius hosted a meeting with 6 USA-based clinics. The intention of the meeting was to discuss the outline of a clinical protocol for trials from phase I to phase III, with the objective of obtaining FDA clearance and reimbursement. By hitting these milestones, the therapy can be widely adopted and improve the outcome of treatment and quality of life of many patients suffering from head and neck cancer. The meeting was presided over by @Jason Molitoris (UoM Baltimore), whereas Mark Hurwitz (MC Westchester) did a presentation on the Mechanism of Action of thermotherapy. Interestingly, whereas the focus in Europe is on the combination of radiotherapy and thermotherapy, the US clinics tend to focus more on the combination of radiochemotherapy and thermotherapy.

Sensius is proud to be recognized as one of the Best Companies of 2024 as Trailblazer of the Immuno-Oncology Frontier by Healthcare Everything. https://lnkd.in/dK93EQ56

We have published a comprehensive positioning paper on mild heat treatment fighting solid tumours in combination with mainstream oncology treatments. It describes the treatment, the underlying mechanisms, reimbursement in various regions, glossary and literature references. Please download the paper here https://lnkd.in/eJFrKU2f

We're #hiring a new Engineering Doctorate in thermotherapy treatment planning and control in Eindhoven, North Brabant. Apply today or share this post with your network.